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Fusion gets in the groove
 
he only confirmed mechanism for protein-mediated 
membrane fusion involves the formation of helix bundles, 
in which helices attached to two membranes pack against one 
another to draw together the membranes. In the final fused 
state, six-helix bundles are formed by HIV Env and paramyxo-
virus F proteins, members of the class I group of viral fusion 
proteins. Although the class I founding member, influenza HA, 
also forms a six-helix bundle, Heather Park, Jennifer Gruenke, 
and Judith White (University of Virginia, Charlottesville, VA) 
now show that this bundle is not sufficient for fusion.
For HA, interactions between a nonhelical region and a trimer 
of helices cause fusion. Using mutational analyses, the group 
shows that fusion requires contacts between a long chain, 
which they call the leash, near the viral membrane with the 
helices near the target membrane (usually a host endosome as 
the virus escapes into the cytoplasm). They suggest that packing 
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of the leash into the 
grooves of the helices 
condenses HA, thus 
bringing together viral 
and host membranes. 
“There’s nothing holy 
about helix–helix inter-
actions as a means 
to pull membranes 
together,” says White. 
Membrane fusion is blocked by muta-
tions in the HA leash region (right).
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“You can do it with other types of interactions.” This may help 
explain why class II viral fusion proteins work although they do 
not have a lot of helical structure.
 
 
 
 
 
Reference:  Park, H.E., et al. 2003. 
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Fold me or leave me
 
ew results from Markus Eser and Michael Ehrmann 
(Cardiff University, Cardiff, UK) indicate that the protein 
that sends secreted proteins through the translocon also 
prevents cytoplasmic proteins from meeting the same fate.
 
 
 
Secreted bacterial 
proteins are targeted 
to and pushed through 
the translocon by 
the protein SecA. 
Because proteins 
must be threaded 
through the translocon 
in an unfolded state, 
the authors guessed 
that SecA might prevent folding of signal sequence–containing, 
and therefore secreted, proteins. Instead, they found just 
the reverse—SecA promotes the folding of proteins that 
lack export signals.
SecA bound to unfolded proteins even if they did not contain 
signal sequences. For proteins lacking an export signal, SecA 
promoted their folding to an active state. Once folded, SecA 
no longer binds, so secretion is thwarted. SecA did not have 
chaperone activity with signal sequence–containing proteins. 
What accounts for this difference is not yet known, but perhaps 
strong binding of SecA to the signal sequence disrupts its 
ability to promote folding. Yeast and human cells do not have 
a SecA homologue, but a different translocon-associated 
chaperone may perform an analogous function. 
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SecA helps proteins fold (right), un-
less they have a signal sequence (left).
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Immune cells take in unknown enemies
 
HC class I molecules normally 
present endogenously synthesized 
antigens and thus activate cytotoxic T 
lymphocytes (CTLs). In antigen-
presenting cells (APCs), however, some 
seemingly extracellular antigens are 
cross-presented: they are loaded onto 
the class I pathway in addition to their 
usual presentation by MHC class II. For 
example, APCs in mice were recently 
shown to activate antipoliovirus CTLs, 
despite lacking a receptor for the virus, 
presumably by cross-presenting polio-
virus antigens on class I. But now Stefan 
Freigang, Rolf Zinkernagel, and 
colleagues (University of Zurich, Zurich, 
Switzerland) show that the missing 
receptor does not stop viral uptake in 
APCs, suggesting that cross-presentation 
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is not needed as an explanation.
“Even in a situation where everybody 
would suspect that cross-presentation is 
going on, we see that APCs are taking in 
the virus,” says Freigang. His group finds 
viral RNA in APCs of the receptorless 
mice. Further, the RNA had to be trans-
lated to elicit CTL 
responses. Thus, even if 
cross-presentation—which 
does not require translation—
might occur, it is too ineffi-
cient under physiological 
infection conditions to cause 
an immune response.
Not all cells are susceptible 
to viral infection, since only 
transgenic mice expressing 
the poliovirus receptor 
develop disease symptoms. So what is 
special about APCs is not clear. “We 
can only speculate on how the virus 
gets into the cell,” says Freigang. 
Perhaps a subset of APCs has the ability 
to take in a variety of pathogens with a 
nonspecific receptor.
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Poliovirus RNA (white) still gets into APCs that lack 
the right receptor.
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